Pfizer’s Duavee Approved For Hot Flashes, Osteoporosis Prevention
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA cleared the single pill combining conjugated estrogens with bazedoxifene, a novel selective estrogen receptor modulator, for two indications but issued a “complete response” letter for use in vulvar and vaginal atrophy.